AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2011
Jul 27, 2011
35124_dirs_2011-07-27_a4ff9af7-62b3-4b94-b344-b9f8f45b496d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-07-25
Reporting Person: LINK MAX (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-07-25 | Celsion Corporation Common Stock | P | 46838 | $4.27 | Acquired | 243942 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-07-25 | Warrant to Purchase Common Stock | $4.22 | P | 18735 | Acquired | 2016-07-25 | Celsion Corporation Common Stock (18735) | Direct |
Footnotes
F1: The securities were purchased in a private placement transaction (the "Private Placement") completed July 25, 2011 between Celsion Corporation and qualified institutional investors as well as a director of Celsion Corporation.
F2: In the Private Placement, the Company sold units, each consisting of one share of the Company's common stock and a warrant to purchase 0.40 shares of the Company's common stock, at a price of $4.27 per unit.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23